Literature DB >> 11705445

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.

C Berry, J McMurray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11705445     DOI： 10.1016/s0002-9343(01)00927-5

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  3 in total

Review 1.  Specialist nurse management programmes: economic benefits in the management of heart failure.

Authors:  Simon Stewart; John D Horowitz
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.

Authors:  Marsha A Raebel; Colleen Ross; Stanley Xu; Douglas W Roblin; Craig Cheetham; Christopher M Blanchette; Gwyn Saylor; David H Smith
Journal:  J Gen Intern Med       Date:  2010-01-20       Impact factor: 5.128

3.  Elevated baseline potassium level within reference range is associated with worse clinical outcomes in hospitalised patients.

Authors:  Sehoon Park; Seon Ha Baek; Sung Woo Lee; Anna Lee; Ho Jun Chin; Ki Young Na; Yon Su Kim; Dong-Wan Chae; Jin Suk Han; Sejoong Kim
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.